CBD SCIENCE
Dead / Abandoned — Abandoned — after ex parte appeal (as of 11 Sept 2023)
What this means for you
This application is over — abandoned 11 Sept 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88326351
- Mark type
- Stylized text
- Filed
- 05 Mar 2019
- Abandoned
- 11 Sept 2023
- Attorney of record
- James David Johnson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pain, disease, illness, and injury; pharmaceutical preparations for the treatment of neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, and metabolic disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for therapeutic purposes in the treatment of pain, disease, illness, and injury; pharmaceutical preparations for the treatment of mental illness; dietary supplements; all of the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Owner
- Boston Research & Development, LLC, Norwood, MA, US
Prosecution history
- 16 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Sept 2023 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 26 Sept 2023 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 11 Sept 2023 — ABANDONMENT - AFTER EX PARTE APPEAL
- 11 Sept 2023 — EXPARTE APPEAL TERMINATED
- 01 Aug 2023 — EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
- 19 May 2023 — NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
- 19 May 2023 — ACTION DENYING REQ FOR RECON E-MAILED
- 19 May 2023 — ACTION CONTINUING FINAL - COMPLETED
- 03 Nov 2022 — AMENDMENT TO USE PROCESSING COMPLETE
- 12 Oct 2021 — USE AMENDMENT FILED
- 29 Sept 2022 — DIVISIONAL PROCESSING COMPLETE
- 12 Oct 2021 — DIVISIONAL REQUEST RECEIVED
- 28 Sept 2022 — ASSIGNED TO LIE
- 03 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL